Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 EV Stocks With Upcoming Catalysts You Can’t Ignore

By Chris MacDonald, InvestorPlace Contributor

These three EV stocks have excellent upside potential for long-term investors looking for ways to play this secular growth trend.

What Happens to Stocks When a Natural Disaster Like Japan’s 7.6 Earthquake Happens?

By Chris MacDonald, InvestorPlace Contributor

Here's what investors may want to consider when it comes to natural disasters like earthquakes when thinking about the markets.

Can These 3 Meme Tokens Climb to New Highs in 2024?

By Chris MacDonald, InvestorPlace Contributor

Investors ought to remain cautious with meme tokens in 2024, despite their impressive relative performance in recent months.

The Year of NIO: Why 2024 Could Be a Gamechanger for the EV Giant

By Chris MacDonald, InvestorPlace Contributor

Here's why long-term EV investors may want to consider Nio and NIO stock, before Chinese manufacturers become the hot ticket in this space.

Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?

By Chris MacDonald, InvestorPlace Contributor

Pfizer is certainly a company that will need to continue to battle headwinds moving forward, but is PFE stock worth a buy?

Load More